New research from a team of Cornell collaborators points to a possible target for antiviral treatment for COVID-19. Their review paper, “Coronavirus Membrane Fusion Mechanism Offers a Potential Target for Antiviral Development,” published April 6 in Antiviral Research. The multidisciplinary group was led by Susan Daniel, associate professor of chemical and biomolecular engineering, and Gary Whittaker, professor of virology at the College of Veterinary Medicine.
